학술논문
Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial
Document Type
Article
Author
Source
In Vaccine 2 April 2024 42(9):2290-2298
Subject
Language
ISSN
0264-410X